Quarterly Transactions Made in Eledon Pharmaceuticals, Inc. (ELDN)
This table provides information about the institutional ownership of Eledon Pharmaceuticals, Inc. (ELDN). The information is specifically focused on institutions that hold shares of Eledon Pharmaceuticals, Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 857,261 | 389,557 | 1,246,818 | 1,016,817 | 246,357 | 1,263,174 | -16,356 | |
Q4 2021 | 389,894 | 81,024 | 470,918 | 628,260 | 428,392 | 1,056,652 | -585,734 | |
Q1 2022 | 1,220,101 | 141,609 | 1,361,710 | 221,224 | 1,872,048 | 2,093,272 | -731,562 | |
Q2 2022 | 16,336 | 4,658 | 20,994 | 483,909 | 49,819 | 533,728 | -512,734 | |
Q3 2022 | 49,311 | 17,988 | 67,299 | 297,737 | 0 | 297,737 | -230,438 | |
Q4 2022 | 362,676 | 14 | 362,690 | 44,464 | 0 | 44,464 | 318,226 | |
Q1 2023 | 7,653 | 73,100 | 80,753 | 8,087 | 0 | 8,087 | 72,666 | |
Q2 2023 | 2,135,330 | 2,202,263 | 4,337,593 | 56,860 | 0 | 56,860 | 4,280,733 | |
Q3 2023 | 123,185 | 23,055 | 146,240 | 174,953 | 0 | 174,953 | -28,713 | |
Q4 2023 | 509,170 | 48,588 | 557,758 | 288,600 | 0 | 288,600 | 269,158 | |
Q1 2024 | 437,957 | 75,626 | 513,583 | 56,740 | 0 | 56,740 | 456,843 | |
Q2 2024 | 4,195,631 | 4,577,176 | 8,772,807 | 77,990 | 0 | 77,990 | 8,694,817 | |
Q3 2024 | 890,922 | 22,527 | 913,449 | 748,220 | 0 | 748,220 | 165,229 |